✦ LIBER ✦

Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study

✍ Scribed by R. Lanzillo; M. Quarantelli; S. Bonavita; G. Ventrella; G. Lus; G. Vacca; A. Prinster; G. Orefice; G. Tedeschi; V. Brescia Morra

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Natalizumab plus interferon beta-1a redu

✍ Ernst-Wilhelm Radue; William H. Stuart; Peter A. Calabresi; Christian Confavreux 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 256 KB

Rationale for early treatment with inter

✍ Frederick E. Munschauer III; William H. Stuart 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 942 KB

Pegylated interferon beta-1a for relapsi

✍ Calabresi, Peter A; Kieseier, Bernd C; Arnold, Douglas L; Balcer, Laura J; Boyko 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 290 KB

Interferon beta treatment in relapsing-r

✍ C. Milanese; L. La Mantia; R. Palumbo 📂 Article 📅 1999 🏛 Springer Milan 🌐 English ⚖ 205 KB

Gender effects on intramuscular interfer

✍ Rudick, R.; Kappos, L.; Kinkel, R.; Clanet, M.; Phillips, J.; Herndon, R.; Sandr 📂 Article 📅 2010 🏛 SAGE Publications 🌐 English ⚖ 229 KB

5-31-07 Interferon beta 1a in the treatm

✍ Ljapcev, R.; Gogovska, L.; Tanovska, M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 180 KB